Merck : MRK

All Merck Articles

1067 Articles

Jon C. Ogg | Sep 25, 2014 at 9:50 AM EDT

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.

Jon C. Ogg | Sep 24, 2014 at 6:45 AM EDT

The Best Performing DJIA Stocks of 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Lee Jackson | Sep 18, 2014 at 8:15 AM EDT

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Here are the four "Gold Standard" stocks from Credit Suisse that offer a combination of a higher yield and more…

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Paul Ausick | Sep 12, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockSeptember 12, 2014: Markets opened lower on Friday as the energy sector and utilities opened weaker. The stronger dollar weakens…

Jon C. Ogg | Sep 11, 2014 at 9:05 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data for the August 29 settlement date is out, and we have decided to look at what…

Paul Ausick | Sep 5, 2014 at 4:01 PM EDT

The 4 Stocks That Lifted the Market

thinkstockSeptember 5, 2014: Markets opened lower on Friday following a disappointing report on employment that investors later took as a…

Jon C. Ogg | Sep 4, 2014 at 4:45 PM EDT

What This Skin Cancer Drug Approval Really Means to Merck

Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.

Paul Ausick | Sep 3, 2014 at 4:01 PM EDT

The 4 Stocks That Steered the Market

thinkstockSeptember 3, 2014: Markets opened higher on Wednesday following a report — later said to be inaccurate — of a…

Lee Jackson | Sep 2, 2014 at 8:30 AM EDT

Top-Yielding Stocks Dominate UBS Equity Focus List for September

In a new research report from the UBS CIO Wealth Management Research team, they continue to have a very favorable…

Trey Thoelcke | Aug 27, 2014 at 1:00 PM EDT

Short Interest Swings in High-Yield Dividend Stocks

4/7 Wall St. reviews short interest in the higher-yield defensive dividend stocks for a sense of what short sellers may…

Paul Ausick | Aug 25, 2014 at 4:01 PM EDT

The 4 Stocks That Helped Lift the S&P Above 2,000

thinkstockAugust 25, 2014: Markets opened higher on Monday, and the S&P pushed above the 2,000 mark for the first time…

Paul Ausick | Aug 14, 2014 at 4:01 PM EDT

The 4 Stocks That Carried the Market

thinkstockAugust 14, 2014: Markets opened higher on Thursday after a slightly worse-than-expected report on new claims for unemployment benefits. U.S.…

Jon C. Ogg | Aug 12, 2014 at 10:42 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

Jon OggThe short interest data is out for the July 31 settlement date. We often review the higher-yield defensive dividend…

Lee Jackson | Aug 1, 2014 at 10:25 AM EDT

UBS Adds New Stocks to Buy to Its Equity Focus List

With interest rates still at historic lows, the stock market is ultimately the only destination for investor capital, and dividend-paying…

1 … 45 46 47 48 49 … 72

Merck : MRK

All Merck Articles

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Helped Lift the S&P Above 2,000

The 4 Stocks That Carried the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

UBS Adds New Stocks to Buy to Its Equity Focus List

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Merck : MRK

All Merck Articles

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Helped Lift the S&P Above 2,000

The 4 Stocks That Carried the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

UBS Adds New Stocks to Buy to Its Equity Focus List

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts